DE69511245D1 - Zusammensetzung und verfahren zur verhinderung und behandlung von entzündung mit immunoglobin a - Google Patents

Zusammensetzung und verfahren zur verhinderung und behandlung von entzündung mit immunoglobin a

Info

Publication number
DE69511245D1
DE69511245D1 DE69511245T DE69511245T DE69511245D1 DE 69511245 D1 DE69511245 D1 DE 69511245D1 DE 69511245 T DE69511245 T DE 69511245T DE 69511245 T DE69511245 T DE 69511245T DE 69511245 D1 DE69511245 D1 DE 69511245D1
Authority
DE
Germany
Prior art keywords
immunoglobin
ignition
treating
preventing
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69511245T
Other languages
English (en)
Other versions
DE69511245T2 (de
Inventor
Martha Eibl
Herrmann Wolf
Josef W Mannhalter
Heinz Leibl
Yendra Linnau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22731867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69511245(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno AG filed Critical Immuno AG
Publication of DE69511245D1 publication Critical patent/DE69511245D1/de
Application granted granted Critical
Publication of DE69511245T2 publication Critical patent/DE69511245T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69511245T 1994-02-18 1995-02-16 Zusammensetzung und verfahren zur verhinderung und behandlung von entzündung mit immunoglobin a Expired - Fee Related DE69511245T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19806794A 1994-02-18 1994-02-18
PCT/EP1995/000571 WO1995022350A1 (en) 1994-02-18 1995-02-16 Composition and method for preventing and treating inflammation with immunoglobulin a

Publications (2)

Publication Number Publication Date
DE69511245D1 true DE69511245D1 (de) 1999-09-09
DE69511245T2 DE69511245T2 (de) 1999-12-16

Family

ID=22731867

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69511245T Expired - Fee Related DE69511245T2 (de) 1994-02-18 1995-02-16 Zusammensetzung und verfahren zur verhinderung und behandlung von entzündung mit immunoglobin a
DE19505287A Withdrawn DE19505287A1 (de) 1994-02-18 1995-02-16 Zusammensetzung und Verfahren zur Prävention und Behandlung von Entzündungen mit Immunglobulin A

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19505287A Withdrawn DE19505287A1 (de) 1994-02-18 1995-02-16 Zusammensetzung und Verfahren zur Prävention und Behandlung von Entzündungen mit Immunglobulin A

Country Status (12)

Country Link
US (1) US5833984A (de)
EP (1) EP0744957B1 (de)
JP (1) JPH09509164A (de)
AT (2) ATE182793T1 (de)
AU (1) AU1809495A (de)
CA (1) CA2183566A1 (de)
DE (2) DE69511245T2 (de)
DK (1) DK0744957T3 (de)
ES (1) ES2135703T3 (de)
GR (1) GR3031691T3 (de)
IT (1) IT1281188B1 (de)
WO (1) WO1995022350A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease
DE19600939C1 (de) * 1996-01-12 1997-08-28 Immuno Ag Verfahren zur Trennung von IgG und IgA
US6344545B1 (en) * 1996-06-14 2002-02-05 Progenics Pharmaceuticals, Inc. Method for preventing HIV-1 infection of CD4+ cells
EP0839915A1 (de) * 1996-11-01 1998-05-06 Institut Suisse De Recherches Experimentales Sur Le Cancer Isrec Sekretorisches Immunglobulin A als schleimhautspezifisches Impfstoffverabreichungssystem
US20020114802A1 (en) * 1998-02-10 2002-08-22 Tjellstrom Bo Arthur Einar Oral immunoglobulin treatment for inflammatory bowel disease
WO2000062806A1 (en) * 1999-04-19 2000-10-26 Richard Weisbart Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
US20020098182A1 (en) * 2000-09-28 2002-07-25 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G
CA2423805A1 (en) * 2000-09-28 2002-04-04 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin g
CA2424623A1 (en) * 2000-10-06 2002-04-11 Richard Weisbart Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
US20040180045A1 (en) * 2001-09-28 2004-09-16 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US8273347B2 (en) * 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US20060057223A1 (en) * 2004-09-10 2006-03-16 Dimauro Thomas M Intradiscal production of autologous interleukin antagonist
WO2009065093A2 (en) * 2007-11-17 2009-05-22 University Of Medicine And Dentistry Of New Jersey Use of stem cells for wound healing
US20090162351A1 (en) * 2007-12-21 2009-06-25 Depuy Spine, Inc. Transdiscal administration of inhibitors of p38 MAP kinase
US8986696B2 (en) 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
CN114894911B (zh) * 2022-03-18 2023-10-24 辽宁成大生物股份有限公司 一种控制牛血清产品质量方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5837285B2 (ja) * 1975-05-29 1983-08-15 カブシキガイシヤ ミドリジユウジ チヨウナイカンセンシヨウチリヨウザイノセイゾウホウホウ
JPS5653622A (en) * 1979-10-09 1981-05-13 Mochida Pharmaceut Co Ltd Preventive and remedy for infectious disease of respiratory organ and oral cavity
JPS5759815A (en) * 1980-09-30 1982-04-10 Mochida Pharmaceut Co Ltd Drug composition having preventing and remedying action on rotavirus infectious disease
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
AT402789B (de) * 1991-03-25 1997-08-25 Immuno Ag Pharmazeutische präparation auf basis von plasmaproteinen

Also Published As

Publication number Publication date
DE19505287A1 (de) 1995-08-24
IT1281188B1 (it) 1998-02-17
EP0744957B1 (de) 1999-08-04
DK0744957T3 (da) 2000-03-06
AT402790B (de) 1997-08-25
US5833984A (en) 1998-11-10
WO1995022350A1 (en) 1995-08-24
AU1809495A (en) 1995-09-04
ATA29495A (de) 1997-01-15
CA2183566A1 (en) 1995-08-24
ES2135703T3 (es) 1999-11-01
EP0744957A1 (de) 1996-12-04
ITTO950112A0 (it) 1995-02-17
DE69511245T2 (de) 1999-12-16
ATE182793T1 (de) 1999-08-15
JPH09509164A (ja) 1997-09-16
ITTO950112A1 (it) 1996-08-17
GR3031691T3 (en) 2000-02-29

Similar Documents

Publication Publication Date Title
DE69511245D1 (de) Zusammensetzung und verfahren zur verhinderung und behandlung von entzündung mit immunoglobin a
ATE320804T1 (de) Behandlung negativer und kognitiver symptome der schizophrenie mit antagonisten der glycinaufnahme
DE68921814T2 (de) VIP-Konjugate und deren aktive Fragmente mit hydrophoben Anteilen und topische Zuberetungen zur Verwendung in der Behandlung männlicher Impotenz.
ATE186834T1 (de) Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut
ATE161143T1 (de) Neue verwendung von hexaflumuron und verwandte verbindungen als termitizide
PT914114E (pt) Metodos de tratamento de hipersensibilidade de tipo i utilizando monofosforil lipido a
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
DE58904683D1 (de) Praeparat mit antikoerperaktivitaet und breitem wirkungsspektrum, daraus bestehende oder diese enthaltende mittel und deren verwendung zur behandlung von bakteriell oder toxin-bedingten erkrankungen und zur bekaempfung von protozoen.
DE60116302D1 (de) Behandlung von seborrhoischer dermatitis
DE4495520T1 (de) Verfahren und pharmazeutische Zusammensetzung zum zielgerichten Anwenden von Wirkstoffen
ATE230609T1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
DE69305267D1 (de) Zusammensetzung zur Behandlung von Mastitis und Metritis
BR9306722A (pt) Dímero de lisozima e composições contendo o mesmo
DE60028559D1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
ES2106183T3 (es) Suero antiveneno.
DE69319341D1 (de) Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion
ATE146175T1 (de) Neue kardioprotektive wirkstoffe
DE69304266D1 (de) Zusammensetzung enthaltend Dibucaine-Hydrochlorid, ein Salicylat, Calciumbromid und ein antiphlogistisches steroid zur Schmerzbekämpfung
KR900701322A (ko) 포도필린과 재조합 DNA인간 α인터페론의 배합물로 생식기 우췌를 치료하는 방법
DE69427949T2 (de) Acriflavine enthaltende Arzneimittel verwendbar zur Behandlung von Herpes und Zona
EE03101B1 (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline kompositsioon
UA26326C2 (uk) Спосіб лікуваhhя захворюваhь вірусhої та бактеріальhої етіології у людиhи і твариhи та композиція для його реалізації
SU1628293A1 (ru) Способ очистки противостолбнячного препарата иммуноглобулина человека

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee